[HTML][HTML] Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

…, V Glover, S Bright, C Butler, JL Cane… - The Lancet …, 2021 - thelancet.com
Background Multiple early reports of patients admitted to hospital with COVID-19 showed
that patients with chronic respiratory disease were significantly under-represented in these …

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

…, L Cureton, R Knight, A Wang, JL Cane… - The Lancet …, 2021 - thelancet.com
Background The antibacterial, anti-inflammatory, and antiviral properties of azithromycin
suggest therapeutic potential against COVID-19. Randomised data in mild-to-moderate disease …

[PDF][PDF] The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells

…, JM Harris, H Borrmann, SB Morgan, JL Cane, L Mailly… - IScience, 2021 - cell.com
The coronavirus disease 2019 pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) coronavirus, is a global health issue with unprecedented …

Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis

WYC Chang, JL Cane, JD Blakey, M Kumaran… - Respiratory …, 2012 - Springer
Background Lymphangioleiomyomatosis is a rare disease occurring almost exclusively in
women. Diagnosis often requires surgical biopsy and the clinical course varies between …

A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis

WYC Chang, JL Cane, M Kumaran… - European …, 2014 - Eur Respiratory Soc
Lymphangioleiomyomatosis (LAM) is characterised by lung cysts and airflow obstruction.
Matrix metalloproteinases have been implicated in lung destruction in LAM. We performed a …

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO

J Camp, JL Cane, M Bafadhel - Medical Sciences, 2018 - mdpi.com
In an era of precision medicine, it seems regressive that we do not use stratified approaches
to direct treatment of oral corticosteroids during an exacerbation of chronic obstructive …

Matrix metalloproteinases-8 and-9 in the airways, blood and urine during exacerbations of COPD

JL Cane, B Mallia-Millanes, DL Forrester… - COPD: Journal of …, 2016 - Taylor & Francis
Matrix metalloproteinases (MMPs) are elevated in the airways and blood of COPD patients,
contributing to disease pathogenesis and tissue remodelling. However, it is not clear if MMP …

Identifying bacterial airways infection in stable severe asthma using Oxford nanopore sequencing technologies

…, D Foster, DW Crook, JL Cane… - Microbiology …, 2022 - Am Soc Microbiol
Previous metagenomic studies in asthma have been limited by inadequate sequencing depth
for species-level bacterial identification and by heterogeneity in clinical phenotyping. We …

A randomised clinical trial of azithromycin versus standard care in ambulatory COVID-19–the ATOMIC2 trial

TSC Hinks, L Cureton, R Knight, A Wang, JL Cane… - medRxiv, 2021 - medrxiv.org
Background The antibacterial, anti-inflammatory and antiviral properties of azithromycin
suggest therapeutic potential against COVID-19. Randomised data in mild-moderate disease …

COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies

…, T Scassellati Sforzolini, J Judy, A Cane… - Expert Review of …, 2022 - Taylor & Francis
Introduction From July through October of 2021, several countries issued recommendations
for increased COVID-19 vaccine protection for individuals with one or more …